Braydon Charles Guild
56Patents
14h-index
16Co-inventors
81Inventor score
Filing activity: Sep 9, 1992 → Aug 7, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5639641A | Resurfacing of rodent antibodies | Chemistry; Metallurgy | 345 | Expired |
| US8853377B2 | mRNA for use in treatment of human genetic diseases | Chemistry; Metallurgy | 119 | Active |
| US8241628B2 | Compositions and methods for antibodies targeting complement protein C5 | Chemistry; Metallurgy | 54 | Active |
| US9181321B2 | CFTR mRNA compositions and related methods and uses | Chemistry; Metallurgy | 37 | Active |
| US9061021B2 | mRNA for use in treatment of human genetic diseases | Chemistry; Metallurgy | 35 | Active |
| US9308281B2 | MRNA therapy for Fabry disease | Human Necessities | 34 | Active |
| US8883158B2 | Compositions and methods for antibodies targeting complement protein C5 | Chemistry; Metallurgy | 30 | Active |
| US10238754B2 | Lipid nanoparticle compositions and methods for MRNA delivery | Human Necessities | 27 | Active |
| US9717690B2 | Cleavable lipids | Chemistry; Metallurgy | 25 | Active |
| US10350303B1 | Lipid nanoparticle compositions and methods for mRNA delivery | Human Necessities | 22 | Active |
| US10413618B2 | Lipid nanoparticle compositions and methods for mRNA delivery | Human Necessities | 22 | Active |
| US9877919B2 | Lipid-derived neutral nanoparticles | Chemistry; Metallurgy | 19 | Active |
| US10143758B2 | Liver specific delivery of messenger RNA | Chemistry; Metallurgy | 19 | Active |
| US10507249B2 | Lipid nanoparticle compositions and methods for mRNA delivery | Human Necessities | 14 | Active |
| US10888626B2 | Lipid nanoparticle compositions and methods for mRNA delivery | Human Necessities | 12 | Active |
| US9713626B2 | CFTR mRNA compositions and related methods and uses | Chemistry; Metallurgy | 11 | Active |
| US11052159B2 | Lipid nanoparticle compositions and methods for mRNA delivery | Human Necessities | 10 | Active |
| US9546128B2 | Ionizable cationic lipids | Chemistry; Metallurgy | 10 | Active |
| US9597413B2 | Pulmonary delivery of mRNA | Human Necessities | 10 | Active |
| US11291734B2 | Lipid nanoparticle compositions and methods for mRNA delivery | Human Necessities | 9 | Active |
| US10130649B2 | Synergistic enhancement of the delivery of nucleic acids via blended formulations | Physics | 9 | Active |
| US10087247B2 | Methods and compositions for delivering mRNA coded antibodies | Chemistry; Metallurgy | 8 | Active |
| US11185595B2 | Lipid nanoparticle compositions and methods for mRNA delivery | Human Necessities | 7 | Active |
| US10702478B2 | Cleavable lipids | Chemistry; Metallurgy | 6 | Active |
| US10137087B2 | Lipid-derived neutral nanoparticles | Chemistry; Metallurgy | 6 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.